ANDREA ALEGRIA ROA: Open Payments
NPI 1336835503 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,928 in 72 payments from 15 companies in 2025. Trend: 2023 $40 · 2024 $527 · 2025 $1,928
Food & beverage: $1,928
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $546 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $329 |
| Celltrion USA Inc. | 7 | $183 |
| Lilly USA, LLC | 8 | $147 |
| Janssen Scientific Affairs, LLC | 2 | $141 |
| Madrigal Pharmaceuticals | 5 | $138 |
| Janssen Biotech, Inc. | 4 | $82 |
| GENZYME CORPORATION | 3 | $75 |
| Novo Nordisk Inc | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
Products named: ENTYVIO, RINVOQ, TREMFYA, OMVOH, REZDIFFRA, DUPIXENT, ZYMFENTRA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
